Richard D. Truesdell, Jr.

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $106.3 million follow-on offering of 3,864,000 shares of common stock of…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Evolent Health, Inc. of $125 million aggregate principal amount of its 2.00% senior convertible notes…

Davis Polk advised the representative of the several underwriters in connection with an SEC-registered secondary offering of 1,568,000 shares of Veritiv Corporation’s common stock by UWW…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering of 7,475,000 shares of common stock of ViaSat, Inc., including 975,000 shares offered…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by AbbVie Inc. of €3.6 billion aggregate principal amount of senior notes in three…

Davis Polk advised the joint book-running managers in connection with the SEC-registered secondary offering of 7,100,000 shares of common stock of MercadoLibre, Inc. by eBay Inc. and eBay’s…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of Callon Petroleum Company’s 6.125% senior…

Davis Polk advised AC Immune SA in connection with its $75.9 million U.S. initial public offering. AC Immune sold 6,900,000 of its common shares in the offering, which included 900,000…

Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 29,900,000 shares of common stock of Callon Petroleum Company (“Callon”). The…